Skip to content
Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

SWISS REJECT OXFORD/ASTRAZENECA VAX

Switzerland announced last week that it would not administer the Oxford/AstraZeneca COVID-19 vaccine because the data “available and evaluated to date [is] not yet sufficient,” the country’s health agency said.
The Financial Times reported there have been concerns about the effectiveness of the shot with people above 65, and countries such as Sweden and Germany have advised against its use in the older population. The paper said the U.K. has already rolled out the vaccine, and its government said it is safe for those over 65.
Bern has approved the Pfizer/BioNTech and Moderna vaccines. The FT reported that the Swiss are apprehensive about getting the vaccine, with about one-third saying they would refuse the jab, the report said.